Steve Schonfeld’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
Steve Schonfeld's CRSP Position: Q3 2026 in Review
Steve Schonfeld opened a new position in CRISPR Therapeutics (CRSP) in Q3 2026: 39,450 shares worth $2.18M. The stake represents 0.01% of the portfolio and ranks #1100 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in CRSP as recently as Q3 2024.
Steve Schonfeld first reported a position in CRSP in Q3 2018 and has held it in 8 quarters since. 504 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- Steve Schonfeld held 39,450 shares of CRISPR Therapeutics worth $2.18M as of Q3 2026.
- CRISPR Therapeutics was a new Steve Schonfeld position in Q3 2026.
- CRISPR Therapeutics made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1100 holding.
- Steve Schonfeld first reported a position in CRISPR Therapeutics in Q3 2018 and has held it in 8 quarters since.
- 504 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.